Download video

TZD' Lightz & TZD' Pangz - The French Touch

3.4K views

LightPGM

3 days ago

TZD' Lightz & TZD' Pangz - The French Touch

TZD' Lightz & TZD' Pangz - The French Touch

【Key Message】Early Optimal Glycemic Control: a Necessity to Prevent T2D Complications
10:52
【Key Message】Early Optimal Glycemic Control: a Necessity to Prevent T2D Complications
by P2PMD
Approaching Integrated Care in T2D and its Related Conditions
0:31
Approaching Integrated Care in T2D and its Related Conditions
by BoehringerUS
TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors
1:10
TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors
by VJOncology
Phase II trial results on enzalutamide and paclitaxel in LAR-enriched TNBC
2:46
Phase II trial results on enzalutamide and paclitaxel in LAR-enriched TNBC
by VJOncology
T2D Diabetes Supplies and Packing Tips
7:45
T2D Diabetes Supplies and Packing Tips
by Kim Not Kimberly
EFL061 - Effectiveness of Lifestyle Intervention in Preventing T2D Based on Genetic Risk
42:52
EFL061 - Effectiveness of Lifestyle Intervention in Preventing T2D Based on Genetic Risk
by Endocrine Society
Telisotuzumab adizutecan in c-Met–expressing refractory mCRC
1:21
Telisotuzumab adizutecan in c-Met–expressing refractory mCRC
by VJOncology
32 Zoledronic Acid Potent Bisphosphonate Therapy and Risks
7:21
32 Zoledronic Acid Potent Bisphosphonate Therapy and Risks
by Pharmacology
An ongoing Phase I\/II dose-finding study of ZN-d5 for R\/R AL amyloidosis
0:48
An ongoing Phase I\/II dose-finding study of ZN-d5 for R\/R AL amyloidosis
by VJHemOnc – Video Journal of Hematology \& HemOnc
9th ECA Webinar: How to 'DiRECT' understanding of t2d into a major advance in clinical care
1:05:12
9th ECA Webinar: How to 'DiRECT' understanding of t2d into a major advance in clinical care
by European Association for the Study of Diabetes
PRESENTATION DUE10062
15:30
PRESENTATION DUE10062
by CZAY